최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of the convergence on culture technology : JCCT = 문화기술의 융합, v.8 no.5, 2022년, pp.29 - 37
정현우 (을지대학교 의료공학과) , 염호준 (을지대학교 의료공학과) , 박상수 (을지대학교 의료공학과)
MDR, a new European medical device regulation newly enacted in 2017, requires that medical device products that have received CE conformity certification through MDD be re-certified by May 2024 in line with the new CE MDR regulation. The new MDR requires more stringent medical device clinical evalua...
National Assembly Budget Office(국회예산정책처). "Evaluation of health and medical policy promotion projects(보건의료정책진흥사업의 평가)." 2005.
S. Park, H. Yeom, H-W. Jeong, "Growth of Korean medical device industry and its global competitiveness." Proceedings of International Promotion of Culture and Technology (PACT) 2022, pp 82-85. June, 2022.
E. Thienpont, G. Quaglio, T. Karapiperis, P. Kjaersgaard-Andersen. "Guest editorial: new medical device regulation in Europe: a collaborative effort of stakeholders to improve patient safety," Clinical Orthopaedics and Related Research, Vol. 478, No. pp. 928-930, 2020. doi: 10.1097/CORR.0000000000001154
R. A. Byrne. "Medical device regulation in Europe-what is changing and how can I become more involved," EuroIntervention. Vol. 15, pp. 647-649, 2019.
R, Beckers, & Z. Kwade, F. Zanca.(). "The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics." Physica Medica, Vol. 83, pp. 1-8, 2021.
S. Janarthanan & R. Kamaraj. "Medical device regulation in US," Research Journal of Pharmacy and Technology, Vo. 13, No. 9, pp. 4453-4456, 2020.
A. Purnama & D. Drago. "FDA regulatory pathways for medical devices." 2019. https://www.topra.org/topra/topra_member/pdfs/CPD-May-2019-Medic al-Devices-and-FDA.pd
F. Geremia. "Quality aspects for medical devices, quality system and certification process." Microchemical Journal, 136, pp. 300-306, 2018.
R. Behan, A. Pandit, & M. Watson. "New EU medical device regulations: Impact on the MedTech sector." Medical Writing, Vol. 26, pp. 20-24, 2017.
S. Chummun, & N.R. McLean. "Poly implant prothese (PIP) breast implants: our experience." The Surgeon, 11(5), 241-245, 2013.
V. Helyar, C. Burke, & S. McWilliams. The ruptured PIP breast implant." Clinical radiology, Vol. 68, No. 8, pp. 845-850, 2013.
S. Oulharj, J. Pauchot, & Y. Tropet, "PIP breast implant removal: a study of 828 cases," Journal of Plastic, Reconstructive & Aesthetic Surgery, Vol. 67, No. 3, pp. 302-307, 2014.
C. Glinski & P. Rott, P. "Regulating certification bodies in the field of medical devices: The PIP breast implants litigation and beyond," European Review of Private Law, Vol. 27, No. 2, pp. 403-428, 2019.
T. Melvin & M. Torre, (2019). "New medical device regulations: the regulator's view," Efort Open Reviews, Vol. 4, No. 6, pp. 351-356, 2019.
B. Wilkinson & R. van Boxtel. "The medical device regulation of the European Union intensifies focus on clinical benefits of devices," Therapeutic innovation & regulatory science, Vol. 54, No. 3, pp. 613-617, 2020.
R. Beckers, Z. Kwade, Z., & F. Zanca. "The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics," Physica Medica, Vol. 83, pp. 1-8, 2021.
J. Malvehy, R. Ginsberg, L. Sampietro-Colom, J. Ficapal, M. Combalia, & P. Svedenhag. (2022). "New regulation of medical devices in the EU: impact in dermatology." Journal of the European Academy of Dermatology and Venereology," Vol. 36, No. 3, pp. 360-364.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.